Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Michaela Lukacova
University of Copenhagen
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
87
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Dapiglutide, a Dual GLP-1 and GLP-2 Receptor Agonist, for Obesity: A Randomised, Double-Blind, Placebo-Controlled Parallel-Group, Proof-of-Concept Trial
Number of pages: 24
Posted: 30 Aug 2025
Casper Kjærsgaard Nielsen
,
Thorir Gauti Pálsson
,
Julie Lyng Forman
, Michaela Lukacova,
Benjamin Anderschou Holbech Jensen
,
David Siersbæk Mathiesen
,
Anders Englund
,
Ida Marie Gether
,
Nicklas Järvelä Jensen
,
Miriam Grøndlund Pedersen
,
Bolette Hartmann
,
Jens J. Holst
,
Filip K. Knop
and
Asger Bach Lund
University of Copenhagen, University of Copenhagen, University of Copenhagen - Section of Biostatistics, University of Copenhagen, University of Copenhagen, University of Copenhagen, University of Copenhagen, University of Copenhagen, University of Copenhagen, University of Copenhagen, University of Copenhagen, University of Copenhagen - Department of Biomedical Sciences, University of Copenhagen - Gentofte Hospital and University of Copenhagen
Downloads
87
(759,537)
View PDF
Download
Abstract:
Obesity, GLP-1/GLP-2 receptor dual agonism, body weight management
Feedback